{"_buckets": {"deposit": "0c19fcc4-f433-4aa8-8a37-d3678ed69c7e"}, "_deposit": {"id": "12522", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "12522"}, "status": "published"}, "_oai": {"id": "oai:niigata-u.repo.nii.ac.jp:00012522", "sets": ["456", "1026"]}, "item_7_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2005-06", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "6", "bibliographicPageEnd": "367", "bibliographicPageStart": "367", "bibliographicVolumeNumber": "119", "bibliographic_titles": [{"bibliographic_title": "新潟医学会雑誌"}, {"bibliographic_title": "新潟医学会雑誌", "bibliographic_titleLang": "en"}]}]}, "item_7_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "1.CYP450による誘導の代表とされるrifampicin 450mg/day一年間投与を経験し,治療域に維持するwarfarin一週間投与量(w/week)が過去10.6年の7.36±0.6mgに対し,31.7±0.49mgと4.3倍に達するのを見た.2.抗脂質血症治療剤であるprobucol投与の44名では維持量は数ヶ月単位で漸増し,また投与中止後でも維持量が数ヶ月単位で漸減した.dihydropyridine系Ca拮抗剤はこれと拮抗し,また動脈塞栓や脳梗塞の予防効果がなく,凝固能亢進が疑われた.", "subitem_description_type": "Abstract"}]}, "item_7_publisher_7": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "新潟医学会"}]}, "item_7_select_19": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_7_source_id_11": {"attribute_name": "書誌レコードID", "attribute_value_mlt": [{"subitem_source_identifier": "AN00182415", "subitem_source_identifier_type": "NCID"}]}, "item_7_source_id_9": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00290440", "subitem_source_identifier_type": "ISSN"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "真島, 正"}], "nameIdentifiers": [{"nameIdentifier": "83516", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2019-08-07"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "KJ00004300242.pdf", "filesize": [{"value": "625.2 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 625200.0, "url": {"label": "KJ00004300242.pdf", "url": "https://niigata-u.repo.nii.ac.jp/record/12522/files/KJ00004300242.pdf"}, "version_id": "4a9855d3-48fc-4622-877a-6b4e520eb0ab"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "departmental bulletin paper", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "5 bucolome併用warfarin投与法II : 薬物相互作用による維持量変動(第242回新潟循環器談話会)", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "5 bucolome併用warfarin投与法II : 薬物相互作用による維持量変動(第242回新潟循環器談話会)"}, {"subitem_title": "5 bucolome併用warfarin投与法II : 薬物相互作用による維持量変動(第242回新潟循環器談話会)", "subitem_title_language": "en"}]}, "item_type_id": "7", "owner": "1", "path": ["456", "1026"], "permalink_uri": "http://hdl.handle.net/10191/2565", "pubdate": {"attribute_name": "公開日", "attribute_value": "2007-05-10"}, "publish_date": "2007-05-10", "publish_status": "0", "recid": "12522", "relation": {}, "relation_version_is_last": true, "title": ["5 bucolome併用warfarin投与法II : 薬物相互作用による維持量変動(第242回新潟循環器談話会)"], "weko_shared_id": null}